Phase 1 Alcoholic Hepatitis Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis
Alcoholic Hepatitis
Prasun Kumar Jalal50 enrolled1 locationNCT05006430
Not Yet Recruiting
Phase 1
Faecal microbiota transplantation in patients with severe alcoholic hepatitis
Severe alcoholic hepatitis
Northern Adelaide Local Health Network (NALHN)40 enrolled4 locationsACTRN12624001051538
Completed
Phase 1
A Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety and Pharmacokinetics of SZN-043, a Novel Bispecific Fusion Protein Targeting ASGR1 and ZNRF3/RNF43, in Healthy Volunteers and Subjects with Liver Cirrhosis
Alcoholic HepatitisLiver Cirrhosis
Surrozen Operating, Inc.40 enrolled1 locationACTRN12622000392763
Not Yet Recruiting
Phase 1
A study to evaluate the safety, tolerability, and pharmacokinetics of a single dose of the drug F-652 in healthy male volunteers.
Alcoholic Hepatitis
Generon Corporation Ltd40 enrolled1 locationACTRN12612000713897